GleamWall
中文EN

FMS Fresenius Medical Care AG IFRS

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1333141 · Reporting currency EUR

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.5%
TTM net income YoY81.9%
TTM EPS YoY83.6%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR13.3%

Margins

Gross margin25.6%
Operating margin9.3%
Net margin5.0%
FCF margin—
EBITDA margin16.8%

Returns

ROE7.0%
ROA3.0%
ROIC (approx.)7.3%
Asset turnover0.61x

Leverage & solvency

Liabilities / assets53.9%
Debt / equity0.55x
Current ratio1.26x
Interest coverage4.87x

Cash quality & payout

Operating cash flow / net income2.74x
Accruals ratio-5.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: EUR 2025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-302024Q22024-06-302024Q12024-03-31
Income statement
Revenue5.07B4.88B4.79B4.88B5.08B4.76B4.77B4.72B
Cost of revenue3.68B3.64B3.58B3.70B3.81B3.61B3.60B3.55B
Gross profit1.39B1.24B1.21B1.18B1.27B1.15B1.17B1.17B
R&D expense38.63M37.75M38.12M43.48M50.06M40.05M45.59M47.80M
SG&A expense784.62M705.44M791.98M750.69M839.56M756.15M771.47M775.64M
Operating income593.86M476.50M425.28M331.39M258.90M462.70M424.79M246.01M
Interest expense89.82M93.10M96.58M95.72M87.29M99.10M103.08M103.85M
Pretax income508.46M402.57M350.55M250.65M179.12M380.53M339.46M157.83M
Income tax106.44M75.22M78.26M61.05M61.00M116.53M99.01M39.51M
Net income327.08M274.80M225.27M151.22M66.90M213.03M187.03M70.96M
EBITDA954.43M834.72M787.31M713.99M650.84M834.79M808.55M633.75M
EPS (basic)—0.940.770.52—0.730.640.24
EPS (diluted)—0.940.770.52—0.730.640.24
Banking
Net interest income-85.39M-73.94M-74.73M-80.74M-79.78M-82.17M-85.33M-88.19M
Balance sheet
Cash & equivalents1.60B1.26B1.72B1.07B1.18B1.37B1.09B1.15B
Inventory2.14B2.09B2.00B2.08B2.07B2.10B2.23B2.22B
Current assets7.90B7.82B8.14B7.96B7.92B8.09B8.69B9.28B
PP&E, netmay include right-of-use assets (IFRS)3.49B3.26B3.29B3.51B3.65B3.51B3.65B3.67B
Goodwill13.57B13.59B13.62B14.64B15.17B14.23B14.81B14.68B
Intangibles1.25B1.25B1.25B1.33B1.37B1.31B1.35B1.36B
Total assets31.00B30.89B31.29B32.74B33.57B32.51B33.90B34.34B
Current liabilities6.25B5.76B5.66B5.45B5.66B5.89B5.94B6.20B
Short-term debt1.60B475.76M989.83M590.56M575.28M942.87M480.83M795.73M
Long-term debt5.69B6.32B6.33B6.15B6.26B6.23B6.85B7.02B
Total debt7.29B6.80B7.32B6.74B6.84B7.18B7.33B7.81B
Total liabilities16.72B16.98B16.96B17.23B17.80B17.72B18.71B19.20B
Shareholders' equity13.31B12.95B13.27B14.37B14.58B13.62B13.93B13.91B
Net debt5.69B5.54B5.60B5.67B5.66B5.81B6.24B6.66B
Shares outstanding279.29M289.85M293.41M293.41M293.41M293.41M293.41M293.41M
Cash flow statement
Operating cash flow1.00B741.56M774.93M162.82M831.70M984.71M442.42M127.31M
Investing cash flow-418.23M-54.01M-142.05M-108.24M-119.19M-219.93M322.55M-68.37M
Financing cash flow-208.39M-1.14B79.22M-138.79M-965.18M-477.08M-837.37M-289.66M
Depreciation & amortization360.57M358.21M362.03M382.60M391.95M372.09M383.76M387.74M
Dividends paid00——00——
Share buybacks434.17M———————

Free plan shows the latest 8 periods; Pro shows all 71 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.